Skip to main content
AD outcomes improved with lebrikizumab and topical steroids
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
AD outcomes improved with lebrikizumab and topical steroids
User login
Username
Password
Reset your password
Concept
Lead
score
Dermatitis
1
1
Cornea and External Disease
0
0.52
Adolescent Medicine
0
0.98
Conjunctivitis
0
0.43
Pruritus
0
0.43
Biologic Therapy
0
0.41
Atopic Dermatitis
0
0.99
Topical Corticosteroid
0
0.37
Corticosteroids
0
0.97
Grant
0
0.26
Steroids
0
0.26
Eczema
0
0.17
Asthma
0
0.16
Continuing Medical Education
0
0.12
Headache
0
0.1
Hypertension
0
0.1
Patient Safety
0
0.1
Adverse Effects
0
0.09
Allergy
0
0.09
Blood
0
0.09
Calcineurin Inhibitor
0
0.09
Canada
0
0.09
Interference
0
0.09
Interleukin
0
0.09
Medical Education
0
0.09
Monoclonal Antibody
0
0.09
Oregon
0
0.09
Pennsylvania
0
0.09
Quality of Life
0
0.09
Severity Index
0
0.09
Sleep
0
0.09
Topical Medication
0
0.09
Specialty
Lead
score
Dermatology
1
1
Allergy & Clinical Immunology
0
0.6
Family Medicine/Primary Care
0
0.8
Pediatrics
0
0.7
Internal Medicine
0
0.9
Pharmacist
0
0.5
Edit Tags